Webinars and Commercial Conversations — Register Now
Tuesday, November 10, 2026, 1:00 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Samuel Caughron, MD, FCAP, Chief Strategy Officer, MAWD Pathology, Medical Director of Laboratory, AdventHealth Kansas City, Medical Director of Laboratory, Labcorp, President, Member & Director, Pathology Ventures, LLC
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, November 18, 2026, 12:00 PM-1 PM ET
Join leading pathology experts, Savitri Krishnamurthy, MD, and Marilyn Bui, MD, PhD, for a webinar exploring potential challenges in HER2 IHC testing for breast cancer, emerging evidence supporting digital and computational pathology as assistive tools for pathologists in HER2 IHC assessment, and practical considerations for real-world implementation and adoption.
Webinar presenters Savitri Krishnamurthy, MD, Professor of Pathology, Department of Anatomical Pathology The University of Texas MD Anderson Cancer Center, Houston, Texas, and Marilyn Bui, MD, PhD, Surgical Pathologist and Cytopathologist Member and Professor, Departments of Pathology, Machine Learning, and Translational Pathology, Scientific Director, Analytic Microscopy Core Chair, Women in Oncology Executive Board Moffitt Cancer Center, Tampa, Florida
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speakers are being compensated for their presentations. The program is not CME accredited and may not be used for CME credit.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers
Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute
CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Siemens Healthcare Diagnostics
| Company | Siemens Healthcare Diagnostics |
|---|---|
| Name of urinalysis instrument | CLINITEK Advantus Analyzer |
| Contact | Aohua Sang |
| City, State | Tarrytown, NY |
| Phone | 914-631-8000 |
| Website | |
| Type of instrument | urine chemistry |
| Instrument list price | $7,392 (avail. via purchase or reagent rental agreement) |
| First year instrument sold in the U.S. | 2006 |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | 3,000/2,000 (in Europe, Asia–Pacific, Latin America, Canada) |
| Foreign countries where company markets instrument | Europe, Asia–Pacific, Latin America, Canada |
| Country where instrument is designed/manufactured | U.S. and United Kingdom/Poland |
| Human languages (other than English) supported | French, German, Italian, Japanese, Spanish, more |
| Intended urine sample volume per day | 36–50 |
| Dimensions (H×W×D) | 12.75 × 15.75 × 13.75 in. |
| Weight fully loaded with reagents/without reagents | 17 lbs./16 lbs. |
| Power requirements | 100–240 VAC (50–60 Hz) |
| Mean time between failure of instrument | 81 days |
| Events that cause instrument to lock or stop analysis | QC failure, short sample, barcode/sample ID misread, result error, sampling error, hardware failure, more |
| • Urine chemistry tests available on instrument in the U.S. | bilirubin (negative–large), hemoglobin (negative–large), glucose (negative–≥1,000 mg/dL), ketone (negative–≥80 mg/dL), leukocyte esterase (negative–large), nitrite (positive/negative), pH (5.0–≥9.0), protein (negative–300 mg/dL), specific gravity (≤1.005–≥1.030), urobilinogen (0.2–≥8.0 EU/dL) |
| • Color compensation pad included/Flagging thresholds customizable | yes/yes |
| • Test strip configuration | loosely packed in bottles |
| • Calibration required after each test strip lot No. change | no |
| • Frequency of customer-performed calibration/Form of calibration | instrument self-calibrates for every strip/dry |
| • How results are displayed for urine chemistry | semiquantitative |
| • Specific gravity correction for protein/glucose | no/no |
| • Microscopy/sediment technology | — |
| • Microscopy/sediment analysis parameters | — |
| • Flagging thresholds customizable | — |
| • Instrument eliminates amorphous crystal interference before sample analysis | — |
| • How results are displayed for microscopy/sediment | — |
| • Reporting format customizable | — |
| • No. of results that can be held in internal memory | — |
| Reagent shelf life/storage temp. for unopened containers of calibrator | — (no calibrator needed) |
| Reagent shelf life/storage temp. for opened containers of calibrator | — (no calibrator needed) |
| Reagent shelf life/storage temp. for unopened containers of control reagent | 730 days/2–8°C |
| Reagent shelf life/storage temp. for opened containers of control reagent | 30 days/20–25°C |
| Reagent barcode-reading capability | yes, for all tests (can read Data Matrix, more) |
| How often quality control samples are run | configurable: 1 hour to 99 days (can use other companies’ QC products) |
| Sample throughput per hour/Time to first result for chemistry | 500/62 seconds, then every 7 seconds |
| Sample throughput per hour/Time to first result for microscopy/sediment | — |
| Analyzer has stat mode | yes |
| FDA approved for body fluid analysis | yes (for urine) |
| Sample dilutions required for urinalysis/body fluid analysis | no/not applicable |
| Minimum width of sample tube/Minimum length of sample tube | 7 mm/76 mm |
| Conditions or substances that prevent a sample from being run | none |
| Means of sample ID entry | barcode scan, manual entry, worklist download from host |
| Built-in liquid-level sensing for samples | no |
| Information that can be barcode scanned on instrument | operator and specimen identifier, reagent lot No., more |
| Compatible with laboratory automation systems | no |
| How LOINC codes for results are made available | functionality not provided |
| Software includes reflex testing/cross-check functionality | no/no |
| Instrument automatically generates consolidated report* | yes |
| Instrument archives patient data | no |
| Instrument connections to transfer information | data-management system that connects to LIS or EHR, directly to LIS or EHR, via commercial middleware, more |
| Interface standards or formats supported | ASTM 1394-91, Siemens proprietary protocol |
| Bidirectional interface | yes, to other companies’ LISs (no third-party tool or software required for interface) |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS and EHR: direct serial, hospital network |
| Information included in transmission to data-management system | device unique identifier, operator ID, specimen ID, result, QC identifier, strip type, reagent lot and expiration |
| Training included with instrument purchase | yes (4 hours at choice of customer or vendor site; follow-up training available for no extra charge) |
| Approximate scheduled maintenance time required | 30 min. per shift; 30 min. daily; 90 min. weekly; 270 min. monthly |
| Onboard diagnostics for troubleshooting | yes |
| Provide list of client sites to potential customers on request | yes (partial list of comparable sites but prospective client must sign a nondisclosure agreement) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | broad test menu: routine UA testing for kidney functions, CKD, AKI, UTI, diabetes mellitus, more; auto-checks proprietary technology for humidity exposure, sample interference, auto. strip ID |
| *chemistry and microscopy results in one report; Note: a dash in lieu of an answer means company did not answer; question or question is not applicable | †also sold via distribution partners |